Abstract
The objective of the present study was to develop floating microballoons of captopril in order to achieve an extended gastric retention in the upper GIT which may enhance the absorption and improve bioavailability. The floating microballoons were formulated with calcium silicate as porous carrier, Eudragit L100 and ethyl cellulose 7 cps as coating polymers and captopril as model drug. The prepared microballoons were evaluated for particle size, angle of repose, Carr’s index, buoyancy studies, drug content and for in vitro drug release. Based upon the dissolution data obtained and various physical parameters evaluated, formulation containing drug to polymer ratio at 1:9 was optimised and further trials were carried out by changing the parameters like temperature, rpm and surfactant concentration to obtain more uniform and stable microballoons. In the optimized formulation, the drug release form was at a steady state manner when compared to the other formulations. The floating drug delivery system of captopril is a promising alternative way of achieving prolonged release with potential for achieving enhanced absorption and bioavailability.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.